lytton laurence w  current holdings  fintelio lytton laurence w current holdings from f d investorlytton laurence w current positions lytton laurence w has disclosed  total holdings in their latest sec filings this investor has not filed a f which indicates it has under m in assets under management aum lytton laurence w s top industries are chemicals and allied products sic   measuring analyzing and controlling instruments photographic medical and optical goods watches and clocks sic   and electric gas and sanitary services  sic   overview sec filings dg predictive value all lytton laurence w holdings are listed in the following table this data is sourced from dg and f filings green rows indicate new positions red rows indicate closed positions add this fundto your dashboard this is a list of d and g filings made since the last quarterly f report if any file dateformsecurity prevshares currentshares changepercent prev valuex current valuex changepercent ‑‑ sc g ardm  aradigm corp   ‑‑ sc g apto  aptose biosciences inc     ‑‑ sc g reph  recro pharma inc   ‑‑ sc ga cbio  catalyst biosciences inc     ‑‑ sc g axsm  axsome therapeutics inc   ‑‑ sc ga cdtx  cidara therapeutics inc     ‑‑ sc ga gnvc  genvec inc     ‑‑ sc ga tcon  tracon pharmaceuticals inc     ‑‑ sc ga vivmf  viveve medical inc     ‑‑ sc ga gig  gigpeak inc   ‑‑ sc ga acpw  active power inc   fintel ir  find the right investors for your company instantly fintel ir combines the comprehensive fintel ownership database with machine learning to provide advanced tools to make investor outreach fast and easy learn more now become a power user join our private investing channel request membership lytton laurence w – filings and transcripts – bamsec toggle navigation product features product details help center pricing contact log in free trial lytton laurence w watch warning large portions of this site require javascript enabled in order to function properly please make sure javascript is enabled in your browser please let us know at supportbamseccom if you have any questions or concerns categorized chronological ownership by owner transcripts your highlights search in documents key exhibits articles of inc  bylaws credit agreements indentures material contracts plans of reorganization underwriting agreements external links sec edgar financials no filings in this category prospectuses and registrations no filings in this category ownership filter sc g aradigm corporation  sc g aptose biosciences inc  sc g recro pharma inc  sc ga catalyst biosciences inc  sc g axsome therapeutics inc  sc g     sc ga     news no filings in this category proxies no filings in this category other no filings in this category see an issue let us know × report an issue what is the issue your email optional fill in if you would like to receive a reply from us cancel report issue × report submitted thank you for reporting the issue if you have provided an email address we will be in touch shortly close × report not submitted sorry your submission did not go through this could be due to a network error or if you are at an investment bank your company disallowing issue report submissions cancel try again free trial features   bamsec inc privacy policy terms of service browse lytton laurence w sc g filing concerning apto on  whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active schedule g filed by lytton laurence w total shares  subject company aptose bioscienc  view complete ownership history backtest filed as of date  event date  overall  ownership  reporting persons name solevoting power sharedvoting power soledispositive power shareddispositive power aggregateamount owned percentof class laurence wlytton       view original filing on edgars raw filing contents txt   hdrsgml    accession number  conformed submission type sc g public document count  filed as of date  date as of change  subject company company data company conformed name aptose biosciences inc central index key  standard industrial classification biological products no diagnostic substances  irs number  state of incorporation a fiscal year end  filing values form type sc g sec act  act sec file number  film number  business address street   airport road suite  street   city mississauga state a zip lv r business phone  mail address street   airport road suite  city mississauga state a zip lv r former company former conformed name aptose biosciences inc formerly lorus therapeutics inc date of name change  former company former conformed name lorus therapeutics inc date of name change  former company former conformed name imutec pharma inc date of name change  filed by company data company conformed name lytton laurence w central index key  filing values form type sc g mail address street   cpw city ny state ny zip  sc g  aptotxt united states securities and exchange commission washington dc  schedule g under the securities exchange act of  name of issuer aptose biosciences inc title of class of securities common stock cusip number t date of event which requires filing of this statement may   check the appropriate box to designate the rule pursuant to which this schedule is filed  rule db  x rule dc  rule dd cusip no t names of reporting persons laurence wlytton  check the appropriate box if a member of a group see instructions a b sec use only citizenship or place of organization usa sole voting power  shared voting power  sole dispositive power  shared dispositive power  aggregate amount beneficially owned by each reporting person  check if the aggregate amount in row  excludes certain shares see instructions percent of class represented by amount in row     based on  common shares issued and outstanding as of may   as reported in the may   k type of reporting person see instructions in item  aname of issuer aptose biosciences inc baddress of issuers principal executive offices  airport road suite  mississauga ontario lv r canada item  aname of person filing laurence w lytton baddress of principal business office or if none residence  cpw ny ny  ccitizenship usa dtitle of class of securities common ecusip number t item  not applicable item ownership aamount beneficially owned  consisting of  shares held by the reporting person and  held in the awl family llc bpercent of class  cnumber of shares as to which the person has isole power to vote or to direct the vote  iishared power to vote or to direct the vote iiisole power to dispose or to direct the disposition of  ivshared power to dispose or to direct the disposition of item ownership of five percent or less of a class if this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than  percent of the class of securities check the following   item ownership of more than five percent on behalf of another person not applicable item identification and classification of the subsidiary which acquired the security being reported on by the parent holding company not applicable item identification and classification of members of the group not applicable item notice of dissolution of group not applicable item certification by signing below i certify that to the best of my knowledge and belief the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect signature after reasonable inquiry and to the best of my knowledge and belief i certify that the information set forth in this statement is true complete and correct  date s laurence w lytton signature laurence w lytton nametitle elevate your investments try it for free lytton laurence w – articles of incorporation – bamsec toggle navigation product features product details help center pricing contact log in free trial lytton laurence w watch warning large portions of this site require javascript enabled in order to function properly please make sure javascript is enabled in your browser please let us know at supportbamseccom if you have any questions or concerns categorized chronological ownership by owner transcripts your highlights search in documents key exhibits articles of inc  bylaws credit agreements indentures material contracts plans of reorganization underwriting agreements external links sec edgar articles of incorporation no filings in this category see an issue let us know × report an issue what is the issue your email optional fill in if you would like to receive a reply from us cancel report issue × report submitted thank you for reporting the issue if you have provided an email address we will be in touch shortly close × report not submitted sorry your submission did not go through this could be due to a network error or if you are at an investment bank your company disallowing issue report submissions cancel try again free trial features   bamsec inc privacy policy terms of service browse lytton laurence w  form  insider transactions × hey there you need to be logged in to do thatno account no sweat…go get started for free once you have your account you can follow companies and start getting email alerts signup login youll love having an account follow companies easily see and explore all your favorites in one place receive alerts get free alerts on as many companies as you want not now get started lytton laurence w insider transactions according to sec form  filings cascade microtech inc  filings  sign up to get alerts when lytton laurence w files a form  get started recent filings  sec form  shares total dollar amount average transaction codes p s a d f i m c e h o x g l w z j k u these are some powerful tools our intelligent investors subscription offers some of the most advanced tools available to help you find signals in the noise upgrade your account to unleash stocktrots full potenial start with a free account advanced basic open market only transaction sizeshares hey there how can we make this page better   send   sign up for free and get  credit towards a premium account limited time only recro pharma inc reph downgraded by zacks investment research  daily political home aboutcontact columnists privacy policy headlines politics nation world issues economy finance recro pharma inc  get news  ratings daily enter your email address below to get the latest news and analysts ratings for recro pharma inc with our free daily email newsletter follow dailypolitical     latest news gulf international bank uk ltd increases stake in zoetis inc zts bemis company inc nysebms shares sold by mitchell mcleod pugh  williams inc energen corporation egn position held by mitchell mcleod pugh  williams inc mitchell mcleod pugh  williams inc has  position in quest diagnostics incorporated nysedgx mitchell mcleod pugh  williams inc has  position in energy transfer equity lp nyseete mitchell mcleod pugh  williams inc has  stake in western gas partners lp wes public storage nysepsa shares bought by gulf international bank uk ltd gulf international bank uk ltd raises stake in regeneron pharmaceuticals inc regn gulf international bank uk ltd acquires  shares of bank of montreal nysebmo general mills inc nysegis expected to post quarterly sales of  billion bank of nova scotia the bns position boosted by gulf international bank uk ltd trinity street asset management llp boosts stake in owensillinois inc nyseoi thestreet inc tst upgraded to buy at zacks investment research trico bancshares tcbk rating lowered to hold at zacks investment research insider buying giyani gold corp tsewdg director acquires c in stock barracuda networks inc cuda svp sells  in stock john h scribante sells  shares of orion energy systems inc oesx stock baystate wealth management llc has  stake in vmware inc vmw smith  nephew plc sn set to announce earnings on wednesday usa compression partners lp announces quarterly dividend of  usac recro pharma inc reph downgraded by zacks investment research july th    comments  filed under  by latisha jones filed under analyst articles  us  finance tweet recro pharma inc nasdaqreph was downgraded by zacks investment research from a “buy” rating to a “hold” rating in a note issued to investors on thursday according to zacks “recro pharma inc is a clinical stage specialty pharmaceutical company it develops nonopioid therapeutics for the treatment of pain in the postoperative setting the company is developing intranasal formulation of dexmedetomidine dex for the treatment of postoperative pain and cancer breakthrough pain sublingual formulation of dex for the treatment of chronic pain and fadolmidine fado a product candidate to treat postoperative pain and neuropathic pain recro pharma inc is based in malvern pennsylvania “ reph has been the subject of several other research reports aegis restated a “buy” rating and set a  price target on shares of recro pharma in a research report on monday march th janney montgomery scott downgraded shares of recro pharma from a “buy” rating to a “fair value” rating and reduced their price target for the stock from  to  in a research report on wednesday june th finally roth capital set a  price target on shares of recro pharma and gave the stock a “buy” rating in a research report on saturday may th two analysts have rated the stock with a hold rating and five have issued a buy rating to the stock the stock currently has a consensus rating of “buy” and a consensus price target of  shares of recro pharma reph opened at  on thursday recro pharma has a month low of  and a month high of  the company’s market capitalization is  million the firm’s day moving average price is  and its day moving average price is  recro pharma nasdaqreph last released its quarterly earnings results on thursday may th the specialty pharmaceutical company reported  earnings per share for the quarter topping the consensus estimate of  by  recro pharma had a negative net margin of  and a negative return on equity of  the firm had revenue of  million during the quarter compared to the consensus estimate of  million on average analysts expect that recro pharma will post  eps for the current fiscal year illegal activity warning this piece of content was originally posted by daily political and is owned by of daily political if you are accessing this piece of content on another domain it was illegally copied and republished in violation of us and international trademark  copyright law the legal version of this piece of content can be viewed at httpswwwdailypoliticalcomrecropharmaincrephdowngradedbyzacksinvestmentresearchhtml in other news major shareholder stonepine capital management sold  shares of the firm’s stock in a transaction that occurred on friday may th the shares were sold at an average price of  for a total transaction of  the sale was disclosed in a filing with the securities  exchange commission which is accessible through this link also insider james e flynn sold  shares of the firm’s stock in a transaction that occurred on thursday june th the stock was sold at an average price of  for a total transaction of  the disclosure for this sale can be found here in the last quarter insiders sold  shares of company stock valued at   of the stock is owned by insiders several hedge funds have recently made changes to their positions in reph janney montgomery scott llc increased its stake in shares of recro pharma by  in the first quarter janney montgomery scott llc now owns  shares of the specialty pharmaceutical company’s stock worth  after buying an additional  shares in the last quarter acadian asset management llc purchased a new stake in shares of recro pharma during the first quarter worth about  wells fargo  company mn increased its stake in shares of recro pharma by  in the first quarter wells fargo  company mn now owns  shares of the specialty pharmaceutical company’s stock worth  after buying an additional  shares in the last quarter bank of new york mellon corp purchased a new stake in shares of recro pharma during the first quarter worth about  finally kcg holdings inc purchased a new stake in shares of recro pharma during the first quarter worth about  institutional investors and hedge funds own  of the company’s stock about recro pharma recro pharma inc is a clinicalstage specialty pharmaceutical company the company is engaged in developing products for hospitals and ambulatory care settings that is developing nonopioid products for treatment of serious acute pain the company’s lead product candidate is an injectable form of meloxicam get a free copy of the zacks research report on recro pharma reph for more information about research offerings from zacks investment research visit zackscom receive news  ratings for recro pharma inc daily  enter your email address below to receive a concise daily summary of the latest news and analysts ratings for recro pharma inc and related companies with marketbeatcoms free daily email newsletter  comment on this post click here to cancel reply name required mail will not be published required website wordpress hashcash needs javascript to work but your browser has javascript disabled your comment will be placed in moderation latest news jeff sessions spoke of resigning after tensions increase with trump president trump’s tweets complicate already complicated week world leaders very critical of paris agreement decision by trump aide to president trump resigns with more expected scudclass missile launched by north korea  dailypolitical llc  all rights reserved privacy policy  about  columnists  contact laurence w lytton  new york ny  intelius sign in we found laurence w lytton in new york ny laurence w lytton intelius found that laurence w lytton is a male between  and  years old from new york ny we have connected them to  addresses  phones and  relatives or associates get report now age laurence w lytton is in his s laurence has lived in new york ny gloversville ny austin tx laurences relatives janice kambara sidney lytton carol panzer kate lytton laurence w lytton zodiac signtaurus gendermale professional status gensym corporation get report now want to know more about laurence get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about laurence or use our people search engine to find others get background check on laurence w lytton get a criminal check on laurence w lytton get a public record report on laurence w lytton get a people search report on laurence w lytton laurence w lyttons contact information known cities lived in find out where laurence w lytton has lived as well as laurence w lyttons phone numbers and email addresses laurence w lytton has lived in  states new york address for laurence w lytton  c a new york ny has lived in new york ny gloversville ny get full address report phone numbers associated with laurence w lytton    new york ny    new york ny    scarsdale ny get full phone report email addresses associated with laurence w lytton lcom get email report laurence w lyttons professional information information regarding laurence w lyttons professional history find out previous places laurence w lytton has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act laurence w lytton has worked at  place company gensym corporation laurence w lyttons experience title company gensym corporation job details founded in  gensym provides the leading realtime expert system development platform for building mission critical process control production control and simulation applications in numerous industries gensyms g software applies realtime rule technology for decisions that optimize operations and that detect diagnose and resolve costly problems gensym and its numerous partners deliver a range of services throughout the world including training software support application consulting and complete solutions additional professional information on laurence w lytton see laurence w lyttons linkedin profile laurence w lyttons social network and potential email matches find out potential social network profiles and potential email usernamed for laurence w lytton laurence w lyttons known social networks and potential email matches find all of laurence w lyttons social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches laurence lytton username matches laurencelytton lyttonlaurence laurencelytton lyttonlaurence laurencelytton lyttonlaurence laurencelytton lyttonlaurence llytton popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches l lytton intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here   forbidden access is denied server error   forbidden access is denied you do not have permission to view this directory or page using the credentials that you supplied form sc ga catalyst biosciences filed by lytton laurence w research stocks news story skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  news  events  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print format change text size default text sizea larger text sizea largest text sizea form sc ga catalyst biosciences filed by lytton laurence w by k wizard—  pm et  httparchivefastedgarcomakcaozfzuirtm filed on may   more cbio news how these biotech stocks are faring  cymabay therapeutics benitec biopharma sage therapeutics and catalyst biosciences pr newswire   am et  catalyst biosciences announces closing of a  million underwritten public offering and full exercise of overallotment option globenewswire   pm et  key milestone reached in catalyst’s subcutaneous factor ix program globenewswire   am et  copyright – fmr llc  all rights reserved  terms of use privacy security site map  stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of  methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top bofi log in for events hafc an earn epam sn log in for events chkp lho fit gts find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  pm et  earnings  dividends  splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  cbio stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventscbio catalyst biosciences inc    as of pm et  quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade price history download to csv file download to excel file log in for more news expand all collapse all brieffinancial milestone achieved in catalysts subcutaneous factor ix program reuters –  am et  catalyst biosciences inc cbio  financial milestone achieved in catalysts subcutaneous factor ix program  catalyst biosciences inc cbio  achieved a financial milestone under its collaboration with isu abxis  catalyst biosciences inc cbio  isu abxis and catalyst plan to have topline data from clinical trial by end of  for cb disu source text for eikon further company coverage financial milestone achieved in catalyst’s subcutaneous factor ix program globenewswire –  am et  catalyst biosciences inc cbio a clinicalstage biopharmaceutical company focused on developing novel medicines to address hematology indications today announced that it has achieved a financial milestone under its collaboration with isu abxis as previously announced isu abxis has completed dosing of the first cohort of up to five patient cohorts in the clinical trial briefcatalyst biosciences factor ix granted orphan drug designation in europe reuters –  am et  catalyst biosciences inc cbio  catalyst biosciences cbio factor ix granted orphan drug designation in europe  catalyst biosciences cbio  european commission granted orphan medicinal product designation to cb disu clinical stage drug candidate for hemophilia b source text for eikon further company coverage catalyst biosciences’ factor ix granted orphan drug designation in europe globenewswire –  am et  catalyst biosciences inc cbio a clinicalstage biopharmaceutical company focused on developing novel medicines to address hematology indications today announced that the european commission has granted orphan medicinal product designation to cb disu a clinical stage drug candidate for hemophilia b the many benefits of orphan medicinal product designation include the potential for cond briefcatalyst biosciences announces achievement of stable normal factor ix blood levels in a preclinical subcutaneous dosing model reuters –  am et  catalyst biosciences inc cbio  catalyst biosciences cbio announces achievement of stable normal factor ix blood levels in a preclinical subcutaneous dosing model source text for eikon further company coverage catalyst biosciences announces achievement of stable normal factor ix blood levels in a preclinical subcutaneous dosing model globenewswire –  am et   data support ongoing clinical trial in individuals with hemophilia b   data to be presented at isth oral session future biotherapeutics for hemophilia a and b  catalyst biosciences inc cbio a clinicalstage biopharmaceutical company focused on developing novel medicines to address hematology indications today announced positive preclinical results of cb disu its nextgeneration todays research report coverage on biotech stocks  jaguar animal health biostage cymabay therapeutics and catalyst biosciences pr newswire –  am et  new york june   dailystocktrackercom has issued research reports on these four stocks jaguar animal health inc jagx biostage inc bstg cymabay therapeutics inc cbay and catalyst biosciences inc cbio according to benzingas research the ishares nasdaq biotechnology index has been up  thus far this year the nyse arca biotech index has added  and the spdr sp biotech has advanced  briefcatalyst biosciences and isu abxis complete dosing of first patient cohort in hemophilia b clinical trial reuters –  am et  catalyst biosciences inc cbio  catalyst biosciences cbio and isu abxis complete dosing of first patient cohort in hemophilia b clinical trial  says plans to have top line data from in hemophilia b clinical trial by end of  source text for eikon further company coverage catalyst biosciences and isu abxis complete dosing of first patient cohort in hemophilia b clinical trial globenewswire –  am et  south san francisco calif and seoul south korea june    catalyst biosciences inc cbio a clinicalstage biopharmaceutical company focused on developing novel medicines to address hematology indications and isu abxis co ltd a commercialstage biopharmaceutical company and catalysts collaborator in the development of its factor ix variant today announced that isu abxis has completed catalyst biosciences announces presentations on its nextgeneration subcutaneous hemophilia product candidates at the  international society on thrombosis and haemostasis isth meeting globenewswire –  am et   factor ix oral presentation  factor viia poster presentation   presentations to summarize the pharmacokinetics and activity of daily subcutaneous dosing in preclinical hemophilia models  catalyst biosciences inc cbio a clinicalstage biopharmaceutical company focused on developing novel medicines to address hematology indications today announced that data from two of its product candid briefcatalyst biosciences’ factor ix recommended for orphan drug designation in europe reuters –  am et  catalyst biosciences inc cbio  catalyst biosciences factor ix recommended for orphan drug designation in europe  catalyst biosciences cbio isu abxis plans to initiate phase  proofofconcept study of cb d in individuals with severe hemophilia b in june in south korea source text for eikon further company coverage catalyst biosciences’ factor ix recommended for orphan drug designation in europe globenewswire –  am et  catalyst biosciences inc cbio a clinicalstage biopharmaceutical company focused on developing novel medicines to address hematology indications today announced that the european medicines agency committee for orphan medicinal products has issued a positive opinion recommending orphan medicinal product designation for cb disu for the treatment of hemophilia b currently approved therapie briefcatalyst biosciences q loss per share  reuters –  am et  catalyst biosciences inc cbio  catalyst biosciences reports first quarter  financial results and provides corporate update  q loss per share   catalyst biosciences inc cbio  cash cash equivalents and shortterm investments as of march   were  million catalyst biosciences reports first quarter  financial results and provides corporate update globenewswire –  am et   raised  million through an underwritten equity offering   factor ix hemophilia b program milestone payment received after completion of indenabling toxicology studies   initiation of hemophilia b phase  proofofconcept clinical trial planned for second quarter of  interim clinical data expected in the second half of   south san francisco calif may    c how these biotech stocks are faring  cymabay therapeutics benitec biopharma sage therapeutics and catalyst biosciences pr newswire –  am et  new york april   on tuesday april   the nasdaq composite the dow jones industrial average and the sp  edged higher at the closing bell httpstockcallerscomregistration catalyst biosciences announces closing of a  million underwritten public offering and full exercise of overallotment option globenewswire –  pm et  catalyst biosciences inc cbio a clinicalstage biopharmaceutical company focused on developing novel medicines to address hematology indications today announced the closing of an underwritten public offering of units for gross proceeds of  million which includes the full exercise of the underwriters overallotment option to purchase additional shares and warrants prior to deducting under key milestone reached in catalyst’s subcutaneous factor ix program globenewswire –  am et   milestone payment received with completion of indenabling toxicology studies   catalysts collaborator isu abxis plans to initiate a phase  proofofconcept study in individuals with severe hemophilia b in the second quarter of   south san francisco calif april    catalyst biosciences inc cbio a clinicalstage biopharmaceutical company focused on developing novel me catalyst biosciences announces pricing of  million underwritten public offering globenewswire –  am et  catalyst biosciences inc cbio a clinicalstage biopharmaceutical company focused on developing novel medicines to address hematology indications today announced the pricing of an underwritten public offering of units for gross proceeds of  million prior to deducting underwriting discounts and commissions and offering expenses payable by catalyst catalyst biosciences announces emergence from key patent opposition period supporting marzeptacog alfa activated catalyst’s lead clinical program globenewswire –  pm et   european patent office indicates that no opposition to catalysts patent has been filed   inc research selected as cro for phase  efficacy clinical trial of factor viia marzeptacog alfa trial expected to commence in the fourth quarter of   south san francisco calif march    catalyst biosciences inc cbio a clinicalstage biopharmaceutical company focused on developing catalyst biosciences announces ind approval in south korea for nextgeneration subcutaneous factor ix program globenewswire –  am et   investigational new drug approval from korean ministry of food and drug safety represents a key milestone in catalysts factor ix development program   catalysts collaborator isu abxis plans to initiate a phase  proofofconcept study in individuals with severe hemophilia b in the second quarter of   south san francisco calif march    catalyst biosciences inc cbio  page page   next  todays and upcoming events aug  cbio to announce q earnings before market confirmed past events last  days jun  shareholders meeting feb  cbio split for  on  announce date  record date  data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming check for social media accounts this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip